AR

Active Director Director DIN 10194215
DIN 10194215 First appointment Jun 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Anu Rani

Data last updated:

Anu Rani is a Director at Dycem Biotech Private Limited (since 2023). Dycem Biotech Private Limited reported revenue of ₹2 Lakh (FY 2024).

DIN 10194215
Primary Designation Director
First Appointment 06 Jun 2023
Oldest Company Age 3 yrs
Largest company Dycem Biotech Private Limited · ₹2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dycem Biotech Private Limited U46497CH2023PTC045117
Director06 Jun 20232023₹2 Lakh (FY 2024)Active

Board colleagues of Anu Rani

NameDINCompanyDesignation
Balwant Singh10194216Dycem Biotech Private LimitedDirector
Jitender Singh10194214Dycem Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dycem Biotech Private Limited
Premium access

Shareholding and investment profile for Anu Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anu Rani

Anu Rani currently holds 1 directorship: Dycem Biotech Private Limited (Director, since 06 Jun 2023, revenue ₹2 Lakh (FY 2024)).

Anu Rani was first appointed on 06 Jun 2023 as Director at Dycem Biotech Private Limited.

The current boards of Anu Rani's companies include Balwant Singh (Dycem Biotech Private Limited), Jitender Singh (Dycem Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available